Jack Stover

Mr. Jack E.
Stover, CPA, is an Independent Director at TransCode Therapeutics, Inc., an Executive Chairman & Chief Executive Officer at Profusa, Inc., an Executive Chairman at Traws Pharma, Inc. and a Chief Executive Officer at Zebec Therapeutics LLC.
He is on the Board of Directors at TransCode Therapeutics, Inc. Mr. Stover was previously employed as an Independent Director by PharmaCyte Biotech, Inc., a Chief Executive Officer & Director by NorthView Acquisition Corp., a President & Director by Quadrant Pharmaceuticals LLC, an Executive Chairman by Targeted Nano Therapeutics LLC, a President, Chief Executive Officer & Director by Interpace Biosciences, Inc., a President, Chief Executive Officer & Director by Antares Pharma, Inc., a Partner by PricewaterhouseCoopers LLP, a Director & Senior Vice President by B. Braun Medical, Inc., a Partner by Coopers & Lybrand LLP, a Director & Executive Vice President by Gynetics, Inc., and a Chief Financial Officer & Executive Vice President by SICOR, Inc. He also served on the board at Viatar CTC Solutions, Inc., Cernostics, Inc., Influmedix, Inc., Arbios Systems, Inc. and PDI, Inc. He received his undergraduate degree from Lehigh University.